June 24 (Reuters) - Correvio Pharma Corp CORV.TO :
* CORREVIO RESUBMITS BRINAVESS (VERNAKALANT) NEW DRUG APPLICATION TO U.S. FDA FOR THE TREATMENT OF PATIENTS WITH RECENT ONSET ATRIAL FIBRILLATION
June 24 (Reuters) - Correvio Pharma Corp CORV.TO :
* CORREVIO RESUBMITS BRINAVESS (VERNAKALANT) NEW DRUG APPLICATION TO U.S. FDA FOR THE TREATMENT OF PATIENTS WITH RECENT ONSET ATRIAL FIBRILLATION